Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing

AuthorsRainey-Smith, Stephanie R
Gu, Yian
Gardener, Samantha L
Doecke, James D
Villemagne, Victor L
Brown, Belinda M
Taddei, Kevin
Laws, Simon M
Sohrabi, Hamid R
Weinborn, Michael
TypeJournal Article (Original Research)
JournalTranslational Psychiatry
Year of Publication2018
URLhttps://www.ncbi.nlm.nih.gov/pubmed/30375373
DOIhttps://doi.org/10.1038/s41398-018-0293-5
AbstractAccumulating research has linked Mediterranean diet (MeDi) adherence with slower cognitive decline and reduced Alzheimer's disease (AD) risk. However, no study to-date has examined the relationship between MeDi adherence and accumulation of cerebral Aβ-amyloid (Aβ; a pathological hallmark of AD) in older adults. Cognitively normal healthy control participants of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Ageing completed the Cancer Council of Victoria Food Frequency Questionnaire at baseline, which was used to construct a MeDi score for each participant (score range 0-9; higher score indicating higher adherence). Cerebral Aβ load was quantified by Pittsburgh Compound B positron emission tomography at baseline, 18 and 36 months: Only individuals categorised as "Aβ accumulators", and thus considered to be on the AD pathway, were included in the analysis (N = 77). The relationship between MeDi adherence, MeDi components, and change in cerebral Aβ load (baseline to 36 months) was evaluated using Generalised Linear Modelling, accounting for age, gender, education, Apolipoprotein E ε4 allele status, body mass index and total energy intake. Higher MeDi score was associated with less Aβ accumulation in our cohort (β = -0.01 ± 0.004, p = 0.0070). Of the individual MeDi score components, a high intake of fruit was associated with less accumulation of Aβ (β = -0.04 ± 0.01, p = 0.00036). Our results suggest MeDi adherence is associated with reduced cerebral AD pathology accumulation over time. When our results are considered collectively with previous data linking the MeDi to slower cognitive decline, it is apparent that MeDi adherence warrants further investigation in the quest to delay AD onset.

http://www.ibas.org.au/what-we-do/publications/3873004


< More publications



HEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDYHEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDY

Interested to participate in a study investigating the effect of fatigue on driving performance?

ARIELARIEL

Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, such as walking or riding a bike, can help make...

Notch monitoring in sleepNOTCH MONITORING IN SLEEP

Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...

IBAS researcher featured on NHMRC Tracker magazineIBAS RESEARCHER FEATURED ON NHMRC TRACKER MAGAZINE

Prof Anne Holland's research on chronic obstructive pulmonary disease is featured as one of the 10 best research topics in the NHMRC publication, Tracker.

Good sleep more essential than ever during COVID-19GOOD SLEEP MORE ESSENTIAL THAN EVER DURING COVID-19

This Sleep Awareness Week, Austin Health's sleep experts remind us all that sleep is integral to good health, particularly at times when we're under stress.

Professor David Berlowitz receives over 7 million in grantsPROFESSOR DAVID BERLOWITZ RECEIVES OVER 7 MILLION IN GRANTS

University of Melbourne Chair of Physiotherapy at Austin Health, Professor David Berlowitz has had quite a memorable week.

Do you have Spinal cord injury? Tired?  Get treated!DO YOU HAVE SPINAL CORD INJURY? TIRED? GET TREATED!

Melbourne researchers have found that 80 percent of people with quadriplegic spinal injuries have sleep apnoea. It's having a big effect on their lives but they don't know they have it, and they don't know it can be treated.

Institute for Breathing and Sleep

Level 5, Harold Stokes Building, Austin Hospital
145 Studley Road
Heidelberg, Victoria, 3084

(03) 9496 5390

Email Us

Donate